(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of 0.56% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.56%.
Neogen's revenue in 2025 is $905,996,000.On average, 2 Wall Street analysts forecast NEOG's revenue for 2026 to be $192,887,333,840, with the lowest NEOG revenue forecast at $192,860,204,056, and the highest NEOG revenue forecast at $192,914,463,623.
In 2027, NEOG is forecast to generate $198,839,608,312 in revenue, with the lowest revenue forecast at $198,090,826,291 and the highest revenue forecast at $199,588,390,333.